|
| |
| |
|
|
|
2002 News Releases
- Dec 23, 2002 - Stock Options Granted
- Nov 29, 2002 - License and Collaboration
Agreement Signed
- Nov 29, 2002 - License And Collaboration Agreement Signed
- GB Simplified Chinese version
- GIF Simplified Chinese version
- Nov 18, 2002 - Non-Brokered Private Placement
- Nov 13, 2002 - Patent "System
for Extracting Tetrodotoxin" issued
by USPTO
- Nov 13, 2002 - International
Wex now owns 97% Of its R&D and Manufacturing facility
- Sept 26, 2002 - Phase I Clinical
Trial Completed in China
- Sept 25, 2002 - Wex invited
to present at BioContact 2002 at Quebec City
- Sept 24, 2002 - 1st Dose Level
of Phase IIa Clinical Trials Completed in Canada
- Sept 19, 2002 - Non-Brokered Private Placement
- Sep 18, 2002 - Licensing Contract
Negotiations to start
- Sept 05, 2002 - Non-Brokered Private Placement
- Aug 08, 2002 - Major Patent
For Pain Management issued by USPTO
- Jul 24, 2002 - Clinical Phase
I Trials Start in China
- Jun 27, 2002 - Letter Of Intent
Signed with European Pharma
- Jun 10, 2002 - Beijing Clinical
Investigation meeting for Clinical Studies in China
- Jun 07, 2002 - Letter Of Understanding
signed by European Pharma
- Jun 04, 2002 - Wex Exhibiting
at World's largest Bio/Conference
- May 29, 2002 - Phase IIa Dosing
for Intractable Cancer Pain with our Platform Drug ongoing
- May 10, 2002 - Clinical Investigators
to meet in Beijing
- May 02, 2002 - Non-Brokered Private Placement
- Apr 22, 2002 - First Patient Dosed
- Apr 04, 2002 - Wex invited to
Address 2002 Overseas Chinese High-Tech Expo
- Apr 01, 2002 - Poster awarded
'Best of Show' at ASCPT
- Mar 27, 2002 - Long Term Efficacy
and Safety Study accepted
- Mar 21, 2002 - Formal IND Approval
in China received
- Mar 06, 2002 - Second Tetrodotoxin Export Order
- Mar 04, 2002 - Engagement Letter
with Canaccord Terminated
- Feb 28, 2002 - Non-Brokered Private Placement
- Feb 27, 2002 - Long-Term Safety
and Efficacy Submission filed
- Feb13, 2002 - Permission Granted
in Canada for Phase II Opiate Study to begin
- Jan 30, 2002 - IND approved
in China
- Jan 22, 2002 - Opiate Withdrawal
Treatment Documents for Phase IIa accepted for review
- Jan 22, 2002 - Non-Brokered Private Placement
- Jan 17, 2002 - Wex's Clinical
Investigator to speak at Major Conference
< 2001 news :: 2003 news >
|
 |
|
|
|
| Home | News | Corporate | Products | Clinical Trials | Investors | Licensing | Contact | |
|
Copyright WEX Pharmaceuticals Inc. All rights reserved.
Privacy Policy | Disclaimer
Website designed by Attention Media.
|
|
